CMS Price Caps: The 2025 Crisis Pharma Can’t Ignore Winning Market Access in a New Era

By Robert H. Philo • April 8, 2025
Bold Strategies to Defy the Odds

505(b)(2) Strategies: Securing U.S. Payer Coverage in 2025 Unlocking Access with Proven Market Access Strategies

By Robert H. Philo, Core Market Access Advisors • April 1, 2025
Proven Strategies for 505(b)(2) Payer Success

Cell Therapy OBAs: The Next Frontier in Payer-Pharma Wins Navigating High Costs with Strategic Collaboration

By By: Robert H. Philo, Core Market Access Advisors • March 25, 2025
"How OBAs Drive Cell Therapy Success"

The Power of Collaboration in Market Access: Bridging Payers and Pharma with Outcomes-Based Agreements

By Robert H. Philo, Core Market Access Advisors • March 24, 2025
"Turning Payer Doubt into Partnership"